Cytel Whitepaper Notes Changes in Clinical Trial Design

February 10, 2021

Advances in computation tools have forever changed clinical trial design and analysis. According to Nobel Prize winning behavioral economists Daniel Kahnemann and Amos Tversky, “statistical intuitions” can be affected by a variety of external factors. Understanding and making these statistical intuitions is an acquired skill and can be immensely useful in the context of high-impact clinical trials.

“As advances in computation and access to computational techniques enable new opportunities for clinical trial design, sponsors will have to gain the ability to detect new routes of questioning and enquiry for maximal benefit to the trial. Cytel’s new whitepaper on the Reimagined Clinical Trials aims to offer an introduction to this new framework of decision-making, powered by advances in computation.” Learn more here.

(Source: Cytel, 1/29/21)

Share This Story!